Page last updated: 2024-08-21

oxazoles and Tobacco Use Disorder

oxazoles has been researched along with Tobacco Use Disorder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Huang, Y; Johnson, B; Li, JX; Liu, J; Wu, R; Zhang, Y1
D'Aniello, E; Damaj, MI; Di Marzo, V; Donvito, G; Giordano, C; Guida, F; Ignatowska-Jankowska, BM; Jackson, A; Lichtman, AH; Maione, S; Mechoulam, R; Muldoon, P; Mustafa, MA; Parker, L; Petrie, GN; Piscitelli, F; Sim-Selley, L; Smoum, R; Vitale, RM1
Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP1

Other Studies

3 other study(ies) available for oxazoles and Tobacco Use Disorder

ArticleYear
Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.
    Addiction biology, 2022, Volume: 27, Issue:1

    Topics: Animals; Behavior, Animal; Male; Nicotine; Oxazoles; Rats; Receptors, G-Protein-Coupled; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder

2022
N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.
    Neuropharmacology, 2019, Volume: 148

    Topics: Animals; Brain Injuries, Traumatic; Cerebral Cortex; Conditioning, Classical; Glycine; Male; Mecamylamine; Mice; Nicotine; Oleic Acids; Oxazoles; PPAR alpha; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine

2019
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Neuropharmacology, 2017, 05-15, Volume: 118

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine

2017